Washington University will host a scientific symposium supported by the National Heart Lung and Blood Institute (NHLBI) and the National Cancer Institute (NCI) to review progress in the application of nanotechnology for the diagnosis, treatment and prevention of cardiovascular disease and cancer. A one and a half day intensive program to educate participants in the current science in nanotechnologies. Oral and poster presentations will be made leading experts, local university faculty, and students.

This symposium is designed to raise awareness and increase the knowledge level of individuals for nanotechnology and to encourage dialogue between the nanotechnology and clinical scientists.
This workshop will highlight the current state-of-the-art on the field of study to develop nanoscale materials to impact the life sciences.


Objectives
This conference is designed to present current state-of-the art nanotechnologies. Which includes:
• Appreciate nanoparticle formulation and invivo applications for cancer and cardiovascular disease
• Understand drug and gene delivery
• Understand cell trafficking with nanoparticles
• Appreciate nanoparticle pharmacokinetics/dynamics and safety profiling